Shares of Novavax Inc. /zigman2/quotes/202614340/composite NVAX +1.14% slid 6.03% to $89.44 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -0.59% rising 0.50% to 14,417.55 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.0091% rising 0.63% to 35,629.33. The stock's fall snapped a three-day winning streak. Novavax Inc. closed $242.24 below its 52-week high ($331.68), which the company achieved on February 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Replimune Group Inc. /zigman2/quotes/203971249/composite REPL +1.39% fell 5.11% to $18.38, VBI Vaccines Inc. /zigman2/quotes/201705917/composite VBIV -6.89% fell 7.56% to $1.59, and AnaptysBio Inc. /zigman2/quotes/205822596/composite ANAB +2.23% fell 2.32% to $31.13. Trading volume (6.0 M) remained 660,422 below its 50-day average volume of 6.6 M.